DSGN insider filings
Design Therapeutics, Inc. — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2026-06-11. Screen DSGN transaction legs live →
Insider transaction summary — last 90 days
No insider filings (Forms 3/4/5) for DSGN between 2026-07-10 and 2026-10-08. The table below lists the most recent filings on record.
Recent insider filings — Design Therapeutics, Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-11 | 4 | Gover Justin D. — Director | Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
| 2026-06-11 | 4 | Berger Heather A. — Director | Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
| 2026-06-11 | 4 | George Simeon — Director, 10% owner | Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
| 2026-06-11 | 4 | LAPPE RODNEY W — Director | Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
| 2026-06-11 | 4 | Shapiro David — Director | Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
| 2026-06-11 | 4 | Schmid John P. — Director | Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
| 2026-04-01 | 4 | Shapiro David — Director | Grant/award (A): 60,000 (derivative) @ $0 · Grant/award (A): 7,500 (derivative) @ $0 | EDGAR |
| 2026-01-05 | 4 | Burgess Julie — Chief Accounting Officer | Grant/award (A): 150,000 (derivative) @ $0 | EDGAR |
| 2026-01-05 | 4 | Jeffries Sean — Chief Operating Officer | Grant/award (A): 375,000 (derivative) @ $0 | EDGAR |
| 2026-01-05 | 4 | Gover Justin D. — Director | Grant/award (A): 45,000 (derivative) @ $0 | EDGAR |
| 2026-01-05 | 4 | Storgard Chris — Chief Medical Officer | Grant/award (A): 250,000 (derivative) @ $0 | EDGAR |
| 2026-01-05 | 4 | Shah Pratik — President, CEO and Chairperson, Director | Grant/award (A): 750,000 (derivative) @ $0 | EDGAR |
| 2025-12-11 | 4 | Shah Pratik — President, CEO and Chairperson, Director | Grant/award (A): 525,000 (derivative) @ $0 · Grant/award (A): 525,000 (derivative) @ $0 | EDGAR |
| 2025-09-10 | 4 | Gover Justin D. — Director | Grant/award (A): 30,000 (derivative) @ $0 · Grant/award (A): 15,833 (derivative) @ $0 | EDGAR |
| 2025-08-14 | 4 | William Arsani — Director | Sale (S): 345,000 @ $5.25 · Sale (S): 217,627 @ $5.25 | EDGAR |
| 2025-06-12 | 4 | William Arsani — Director | Grant/award (A): 19,000 (derivative) @ $0 | EDGAR |
| 2025-06-12 | 4 | Prasad Deepa — Director | Grant/award (A): 19,000 (derivative) @ $0 | EDGAR |
| 2025-06-12 | 4 | Berger Heather A. — Director | Grant/award (A): 19,000 (derivative) @ $0 | EDGAR |
| 2025-06-12 | 4 | George Simeon — Director, 10% owner | Grant/award (A): 19,000 (derivative) @ $0 | EDGAR |
| 2025-06-12 | 4 | LAPPE RODNEY W — Director | Grant/award (A): 19,000 (derivative) @ $0 | EDGAR |
| 2025-06-12 | 4 | Schmid John P. — Director | Grant/award (A): 19,000 (derivative) @ $0 | EDGAR |
| 2025-05-23 | 4 | Storgard Chris — Chief Medical Officer | Grant/award (A): 400,000 (derivative) @ $0 | EDGAR |
| 2025-01-06 | 4 | Burgess Julie — Chief Accounting Officer | Grant/award (A): 135,000 (derivative) @ $0 | EDGAR |
| 2025-01-06 | 4 | Jeffries Sean — Chief Operating Officer | Grant/award (A): 260,000 (derivative) @ $0 | EDGAR |
| 2025-01-06 | 4 | Shah Pratik — President, CEO and Chairperson, Director | Grant/award (A): 600,000 (derivative) @ $0 | EDGAR |
| 2025-01-06 | 4 | LAPPE RODNEY W — Director | Grant/award (A): 25,993 (derivative) @ $0 | EDGAR |
| 2024-12-19 | 4 | Prasad Deepa — Director | Sale (S): 3,806 @ $6.27 | EDGAR |
| 2024-08-12 | 4 | William Arsani — Director | Sale (S): 814,874 @ $4.25 | EDGAR |
| 2024-06-17 | 4 | William Arsani — Director | Grant/award (A): 19,000 (derivative) @ $0 | EDGAR |
| 2024-06-17 | 4 | Prasad Deepa — Director | Grant/award (A): 19,000 (derivative) @ $0 | EDGAR |
| 2024-06-17 | 4 | Berger Heather A. — Director | Grant/award (A): 19,000 (derivative) @ $0 | EDGAR |
| 2024-06-17 | 4 | George Simeon — Director, 10% owner | Grant/award (A): 19,000 (derivative) @ $0 | EDGAR |
| 2024-06-17 | 4 | LAPPE RODNEY W — Director | Grant/award (A): 19,000 (derivative) @ $0 | EDGAR |
| 2024-06-17 | 4 | Schmid John P. — Director | Grant/award (A): 19,000 (derivative) @ $0 | EDGAR |
| 2024-03-25 | 4 | Berger Heather A. — Director | Purchase (P): 1,300 @ $3.74 | EDGAR |
| 2024-03-25 | 4 | Schmid John P. — Director | Purchase (P): 9,156 @ $3.62 · Purchase (P): 17,809 @ $3.74 | EDGAR |
| 2024-01-05 | 4 | Burgess Julie — Chief Accounting Officer | Grant/award (A): 110,000 (derivative) @ $0 | EDGAR |
| 2024-01-05 | 4 | Jeffries Sean — Chief Operating Officer | Grant/award (A): 350,000 (derivative) @ $0 | EDGAR |
| 2023-12-05 | 4 | Ansari Aseem Z. — 10% owner | Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
| 2023-12-05 | 4 | LAPPE RODNEY W — Director | Grant/award (A): 69,186 (derivative) @ $0 | EDGAR |
| 2023-10-02 | 4 | LAPPE RODNEY W — Director | Purchase (P): 21,000 @ $2.35 | EDGAR |
| 2023-09-06 | 4/A | William Arsani — Director | Conversion (C): 1,217,627 · Conversion (C): 814,874 · Purchase (P): 700,000 @ $20 | EDGAR |
| 2023-09-05 | 4 | Shah Pratik — President, CEO and Chairperson, Director | Grant/award (A): 1,050,000 (derivative) @ $0 · Grant/award (A): 525,000 (derivative) @ $0 · Grant/award (A): 525,000 (derivative) @ $0 | EDGAR |
| 2023-08-30 | 4 | Prasad Deepa — Director | Purchase (P): 12,000 @ $2.31 | EDGAR |
| 2023-08-30 | 4 | William Arsani — Director | Purchase (P): 275,000 @ $2.15 · Purchase (P): 1,960,000 @ $2.44 | EDGAR |
| 2023-06-02 | 4 | Berger Heather A. — Director | Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
| 2023-06-02 | 4 | Xu Stella — Director | Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
| 2023-06-02 | 4 | George Simeon — Director, 10% owner | Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
| 2023-06-02 | 4 | LAPPE RODNEY W — Director | Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
| 2023-06-02 | 4 | Schmid John P. — Director | Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
Recent 8-K events — Design Therapeutics, Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-08-03 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-11 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2026-05-18 | 8-K | 8.01 — Other Events | EDGAR |
| 2026-04-28 | 8-K | 2.02 — Results of Operations and Financial Condition 7.01 — Regulation FD Disclosure | EDGAR |
| 2026-04-01 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2026-03-09 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-01-30 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2025-11-05 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-09-10 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2025-08-07 | 8-K | 2.02 — Results of Operations and Financial Condition 7.01 — Regulation FD Disclosure | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=DSGN returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →